TrialBMC cancer2017

The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-center, single-arm, phase II study (CCOG-0902).

Goro Nakayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.